SMX (Security Matters) Public Limited Company — Form 6-K Summary
Business context and reporting period
This Form 6-K, filed January 25, 2024, reports transactions completed on or about January 12, 2024 under agreements dated December 31, 2023. The transactions involved the settlement of existing convertible notes, redeemable warrants, and amounts owed to a service provider through the issuance of ordinary shares and warrants.
Key financial and capital structure metrics
| Item | Reported amount |
|---|---|
| Shares issued to note holders | 4,032,256 ordinary shares |
| Warrants issued to note holders | 4,032,256 warrants |
| Existing note obligations cancelled | Approximately $750,000 |
| Redeemable warrant value cancelled | $1,450,000 |
| Shares issued to service provider | 457,682 ordinary shares |
| Services settled | $260,000 |
| Total ordinary shares issued in the transactions | 4,489,938 |
| Warrant exercise price | $1.17 per share |
| Warrant term | From issuance through the fifth anniversary of issuance |
The filing does not provide revenue, profit, cash flow, margin, cash balance, or debt and liquidity metrics beyond the obligations settled in these transactions.
Material changes versus the prior comparable period
- The Company reduced or cancelled approximately $750,000 of convertible note obligations and $1.45 million of redeemable warrant value without a reported cash payment.
- The Company settled $260,000 of previously provided services through the issuance of ordinary shares.
- The transactions increased the number of outstanding ordinary shares by 4,489,938 and created warrants to purchase 4,032,256 additional ordinary shares.
- The shares and warrants were issued at a conversion price equal to a 20% discount to the last closing share price on December 31, 2023. The filing does not state the resulting per-share conversion price.
Terms, outlook, risks, and unusual items
- Each warrant has a $1.17 exercise price, may be exercised in whole or in part, and permits cashless exercise at the fixed $1.17 price, subject to the warrant terms.
- The exercise price and underlying share count are subject to customary adjustments for stock splits, stock dividends, recapitalizations, combinations, and similar events. The Board may reduce the exercise price during the warrant term, subject to principal-market rules.
- The warrants have no established trading market, are not expected to develop an active trading market, and will not be listed by the Company on a securities exchange or other trading market. Their liquidity is therefore expected to be extremely limited.
- Warrant holders generally have no shareholder voting rights or other shareholder privileges until exercise, although the warrants provide participation rights in distributions or dividends on ordinary shares.
- The warrant terms include protections in a Fundamental Transaction and permit amendments or waivers with the Company’s and the applicable holder’s written consent.
- The Company agreed to file a registration statement intended to make the issued shares and the shares underlying the warrants fully tradable as of January 28, 2024. The filing does not confirm that the registration statement was filed or became effective.
- The securities were issued in reliance on Section 4(a)(2) and/or Regulation S. They were not registered under the Securities Act and cannot be offered or sold in the United States absent registration or an applicable exemption.
Important facts for investors to verify
- Whether the registration statement was filed and became effective by January 28, 2024.
- The Company’s post-transaction outstanding share count and the potential dilution from 4,032,256 warrants.
- The exact conversion price implied by the 20% discount to the December 31, 2023 closing price.
- The accounting treatment and balance-sheet impact of cancelling the notes, redeemable warrants, and service-provider obligation.
- Whether any warrants have been exercised, modified, repriced, or otherwise amended since issuance.
- The Company’s current cash position, liquidity needs, and other outstanding debt or financing obligations, which are not detailed in this filing.